Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
Poland, Moderna Working Towards Increased Flexibility Of COVID-19 Vaccine Contracts: Reuters
April 25, 2022
From Benzinga
Valneva Receives More Questions From European Regulator For Its COVID-19 Vaccine, Shares Fall
April 25, 2022
From Benzinga
From Benzinga
From Benzinga
World's Largest Vaccine Manufacturer Stops Making COVID-19 Vaccines As 200M Doses Pile-Up: Bloomberg
April 22, 2022
From Benzinga
Celsion's Formulated DNA Plasmid COVID-19 Vaccine Candidate Shows Activity Against Two Strains
April 21, 2022
Tickers
CLSN
From Benzinga
From Benzinga
From Benzinga
From Benzinga
AstraZeneca's COVID-19 Antibody Provides Protection For At Least Six Months In High-Risk Individuals
April 21, 2022
From Benzinga
Codiak BioSciences's Pan Beta-Coronavirus Vaccine Shows Encouraging Action In Animal Studies
April 21, 2022
Tickers
CDAK
From Benzinga
Moderna Says Dual Variant COVID-19 Booster With Beta is Better Effective Against Omicron Than Current Jab
April 19, 2022
Tickers
MRNA
From Benzinga
From Benzinga
From Benzinga
Pfizer/BioNTech Fourth COVID-19 Vaccine Dose Protects Against Omicron For At Least One Month
April 18, 2022
From Benzinga
Two long COVID Patients Recover After Pfizer's Therapy; Side Effects, Safety Needs To Be Assessed: Reuters
April 18, 2022
Tickers
PFE
From Benzinga
From Benzinga
As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ
April 18, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Pfizer/BioNTech's COVID-19 Vaccine Booster Shows High Immune Response In Kids Aged 5-11 Years
April 14, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.